Three-Year asthma injection trial seeks to reduce severe attacks

NCT ID NCT06033833

Summary

This study is testing the long-term safety and effectiveness of an injectable drug called amlitelimab for adults with moderate-to-severe asthma. It follows 335 people who were already in a previous amlitelimab study, tracking them for up to 3 years to see if the drug continues to control asthma and prevent serious flare-ups. The main goal is to understand the drug's safety profile and whether it helps reduce hospital visits and improve breathing over a long period.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Bensch Clinical Research LLC- Site Number : 8400004

    Stockton, California, 95207, United States

  • Centro de Diagnostico e Pesquisa da Osteoporose do Espirito Santo- Site Number : 0760002

    Vitória, Espírito Santo, 29055-450, Brazil

  • Clínica de Alergia Martti Antila- Site Number : 0760003

    Sorocaba, 18040-425, Brazil

  • Helix Biomedics, LLC - Site Number : 8400029

    Boynton Beach, Florida, 33435, United States

  • Hospital Sao Lucas da PUCRS- Site Number : 0760006

    Porto Alegre, Rio Grande do Sul, 90610-000, Brazil

  • Hospital das Clinicas de Sao Paulo- Site Number : 0760008

    São Paulo, São Paulo, 05403-000, Brazil

  • Instituto Méderi de Pesquisa e Saúde- Site Number : 0760001

    Passo Fundo, Rio Grande do Sul, 99010-170, Brazil

  • Investigational Site Number : 0320001

    Ciudad Autonoma Buenos Aires, C1425BEN, Argentina

  • Investigational Site Number : 0320002

    CABA, Buenos Aires, C1425FVH, Argentina

  • Investigational Site Number : 0320003

    Ciudad Autonoma Buenos Aires, C1414AIF, Argentina

  • Investigational Site Number : 0320004

    Ciudad Autonoma Bs As, C1121ABE, Argentina

  • Investigational Site Number : 0320005

    Rosario, Santa Fe Province, S2000JKR, Argentina

  • Investigational Site Number : 0320006

    Rosario, Santa Fe Province, 2000, Argentina

  • Investigational Site Number : 0320007

    Rosario, Santa Fe Province, S2000DEJ, Argentina

  • Investigational Site Number : 0320008

    La Plata, Buenos Aires, B1900BNN, Argentina

  • Investigational Site Number : 0320009

    Buenos Aires, Buenos Aires F.D., 1060, Argentina

  • Investigational Site Number : 1240007

    Trois-Rivières, Quebec, G8T 7A1, Canada

  • Investigational Site Number : 1240008

    Ottawa, Ontario, K1G 6C6, Canada

  • Investigational Site Number : 1520001

    Santiago, Reg Metropolitana de Santiago, 7500692, Chile

  • Investigational Site Number : 1520003

    Santiago, Reg Metropolitana de Santiago, 7750495, Chile

  • Investigational Site Number : 1520005

    Quillota, Región de Valparaíso, 2260877, Chile

  • Investigational Site Number : 1520006

    Talca, Maule Region, 3465584, Chile

  • Investigational Site Number : 1520008

    Santiago, Reg Metropolitana de Santiago, 8380465, Chile

  • Investigational Site Number : 3480006

    Püspökladány, 4150, Hungary

  • Investigational Site Number : 3480009

    Edelény, 3780, Hungary

  • Investigational Site Number : 3480011

    Gödöllö, 2100, Hungary

  • Investigational Site Number : 3480012

    Százhalombatta, 2440, Hungary

  • Investigational Site Number : 3800001

    Verona, 37134, Italy

  • Investigational Site Number : 3800003

    Rome, Roma, 00168, Italy

  • Investigational Site Number : 3800004

    Naples, 80131, Italy

  • Investigational Site Number : 3920001

    Shinagawa-ku, Tokyo, 140-8522, Japan

  • Investigational Site Number : 3920004

    Chuo-ku, Tokyo, 104-0031, Japan

  • Investigational Site Number : 3920005

    Chuo-ku, Tokyo, 103-0027, Japan

  • Investigational Site Number : 3920010

    Sakai, Osaka, 591-8555, Japan

  • Investigational Site Number : 3920019

    Hiroshima, 732-0052, Japan

  • Investigational Site Number : 4100001

    Seoul, Seoul-teukbyeolsi, 03722, South Korea

  • Investigational Site Number : 4100002

    Seoul, Seoul-teukbyeolsi, 138-878, South Korea

  • Investigational Site Number : 4100004

    Daegu, Daegu, 42415, South Korea

  • Investigational Site Number : 4100005

    Seoul, Seoul-teukbyeolsi, 05030, South Korea

  • Investigational Site Number : 4100006

    Moncton, Seoul-teukbyeolsi, E1C 6Z8, South Korea

  • Investigational Site Number : 4840001

    Guadalajara, Jalisco, 44100, Mexico

  • Investigational Site Number : 4840002

    Chihuahua City, 31000, Mexico

  • Investigational Site Number : 4840005

    Guadalajara, Jalisco, 44670, Mexico

  • Investigational Site Number : 4840008

    Mérida, 97070, Mexico

  • Investigational Site Number : 6160001

    Poznan, Greater Poland Voivodeship, 60-693, Poland

  • Investigational Site Number : 6160002

    Gdansk, 80-405, Poland

  • Investigational Site Number : 6160003

    Elblag, 82-300, Poland

  • Investigational Site Number : 6160004

    Bialystok, Podlaskie Voivodeship, 15-044, Poland

  • Investigational Site Number : 6160006

    Krakow, Lesser Poland Voivodeship, 31-559, Poland

  • Investigational Site Number : 6160007

    Tarnów, 33-100, Poland

  • Investigational Site Number : 7100001

    Cape Town, 7937, South Africa

  • Investigational Site Number : 7100002

    Cape Town, 7530, South Africa

  • Investigational Site Number : 7100004

    Middelburg, 1055, South Africa

  • Investigational Site Number : 7100007

    Benoni, 1501, South Africa

  • Investigational Site Number : 7920001

    Istanbul, 34098, Turkey (Türkiye)

  • Investigational Site Number : 7920002

    Mersin, 33070, Turkey (Türkiye)

  • Investigational Site Number : 7920003

    Izmir, 35100, Turkey (Türkiye)

  • Investigational Site Number : 7920005

    Kocaeli, 41100, Turkey (Türkiye)

  • Investigational Site Number : 7920008

    Kayseri, 38039, Turkey (Türkiye)

  • Investigational Site Number : 8260001

    Bradford, BD9 6RJ, United Kingdom

  • Irmandade da Santa Casa de Misericordia de Porto Alegre- Site Number : 0760007

    Porto Alegre, Rio Grande do Sul, 90020-090, Brazil

  • Johns Hopkins University School of Medicine- Site Number : 8400012

    Baltimore, Maryland, 21224, United States

  • OK Clinical Research, LLC- Site Number : 8400001

    Edmond, Oklahoma, 73034, United States

  • Pines Care Research Center LLC- Site Number : 8400028

    Pembroke Pines, Florida, 33025, United States

  • Proar- Site Number : 0760004

    Salvador, Estado de Bahia, 40060-330, Brazil

  • Savin Medical Group - Miami- Site Number : 8400015

    Miami, Florida, 33126, United States

  • TTS Research- Site Number : 8400011

    Boerne, Texas, 78006, United States

  • Treasure Valley Medical Research- Site Number : 8400031

    Boise, Idaho, 83706, United States

Conditions

Explore the condition pages connected to this study.